- Warfarin and other Anticoagulants: Monitoring of Patients during the COVID-19 Pandemic
- Methotrexate Once Weekly for Autoimmune Diseases: New Measures to Reduce Risk of Fatal Overdose due to Inadvertent Daily Instead of Weekly Dosing
- Nivolumab (Genetical Recombination): Revision of Precautions
- Tecentriq (Atezolizumab): A New Identified Risk of Severe Cutaneous Adverse Reactions
- Montelukast: Increased Risk of Neuropsychiatric Events
- Systemic and Inhaled Fluoroquinolones: Risk of Heart Valve Regurgitation/Incompetence
- Transdermal Fentanyl Patches for Non-cancer Pain: Do Not Use in Opioid-naive Patients
- Flucytosine: New Contraindication in Patients with DPD Deficiency
- Injection Heparin related Gastric Bleeding
Drug Safety Alerts – January
by
Tags:
Leave a Reply